Top Markets
Coin of the day
Eurobio Scientific Société anonyme Eurobio Scientific Société anonyme

Eurobio Scientific Société anonyme

ALERS
Rangering i aksjer #10866
Eurobio Scientific Société anonyme designs, develops, and commercializes... Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Aksjekurs
$25.15
Markedsverdi
$253.18M
Endring (1 dag)
0.00%
Endring (1 år)
-12.08%
Land
FR
Handel Eurobio Scientific Société anonyme (ALERS)

Kategori

Inntekter for Eurobio Scientific Société anonyme (ALERS)
Inntekter i Dec 2025 TTM: $197.93M
Ifølge de nyeste økonomiske rapportene til Eurobio Scientific Société anonyme er selskapets nåværende inntekter (TTM) $197.93M. I 2023 hadde selskapet inntekter på $144.42M en nedgang sammenlignet med inntektene i 2022, som var $163.70M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Eurobio Scientific Société anonyme fra 2007 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $197.93M 22.76%
2024 $161.23M 11.64%
2023 $144.42M -11.77%
2022 $163.70M -22.07%
2021 $210.04M -8.68%
2020 $230.00M 244.68%
2019 $66.73M 13.70%
2018 $58.69M 14.33%
2017 $51.33M 75.33%
2016 $29.28M -9.46%
2015 $32.34M -13.91%
2014 $37.56M -12.50%
2013 $42.93M 504.10%
2012 $7.11M 9.96%
2011 $6.46M -42.58%
2010 $11.25M 60.45%
2009 $7.01M 19.30%
2008 $5.88M -25.30%
2007 $7.87M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$45.13B 22,702.70%
US
$25.27B 12,666.97%
US
$36.37B 18,275.31%
IE
$20.62B 10,315.16%
US
$6.30B 3,084.67%
US